Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Bicarbonate (mixed), typically referring to sodium bicarbonate, has a historical role in the management of gout, primarily predating the widespread use of modern urate-lowering therapies. The rationale for its use stems from its ability to alkalinize the urine, thereby increasing the solubility of uric acid and potentially reducing the risk of uric acid crystal formation in the urinary tract. In the early to mid-20th century, sodium bicarbonate was sometimes recommended as an adjunct to dietary measures in gout patients, particularly to help prevent uric acid nephrolithiasis (kidney stones). However, there is scant direct scientific evidence from controlled studies supporting a significant clinical benefit in treating acute gout attacks or chronically lowering serum uric acid levels using bicarbonate. Modern gout management focuses on medications such as allopurinol, febuxostat, and colchicine, which directly lower uric acid or address inflammation. While urine alkalinization with bicarbonate may still be considered in specific cases of uric acid kidney stones, its routine use for gout is not endorsed by current clinical guidelines. Thus, its application is primarily supported by tradition and historical practice, with only a modest theoretical rationale and limited supporting evidence.

More about Bicarbonate (mixed)
More about Gout